Wildcat Capital Management as of March 31, 2017
Portfolio Holdings for Wildcat Capital Management
Wildcat Capital Management holds 15 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Kite Pharma | 58.6 | $185M | 2.4M | 78.49 | |
| CoStar (CSGP) | 12.5 | $40M | 191k | 207.22 | |
| POWERSHS DB US Dollar Index | 8.1 | $26M | 985k | 25.95 | |
| Nantkwest | 5.0 | $16M | 4.5M | 3.55 | |
| Sorrento Therapeutics (SRNE) | 3.5 | $11M | 2.8M | 3.95 | |
| MiMedx (MDXG) | 3.3 | $10M | 1.1M | 9.53 | |
| Lpl Financial Holdings (LPLA) | 2.6 | $8.2M | 207k | 39.83 | |
| iShares JPMorgan USD Emer Mkt Bnd Fd ETF (EMB) | 2.5 | $7.9M | 70k | 112.83 | |
| Uniti Group Inc Com reit (UNIT) | 1.3 | $4.2M | 163k | 25.85 | |
| Ishares Nasdaq Biotech Indx call | 0.9 | $2.8M | 9.6k | 292.86 | |
| CurrencyShares Japanese Yen Trust | 0.9 | $2.7M | 31k | 86.51 | |
| Nanthealth | 0.4 | $1.2M | 239k | 4.96 | |
| Editas Medicine (EDIT) | 0.3 | $922k | 41k | 22.31 | |
| Tesla Motors Inc cmn | 0.1 | $306k | 1.1k | 278.18 | |
| Adverum Biotechnologies | 0.0 | $41k | 15k | 2.73 |
